Clinical trial
Inhaled Sargramostim in Treating Patients With First Pulmonary (Lung) Recurrence…
NCT00066365 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00066365 |
|---|---|
| Title | Inhaled Sargramostim in Treating Patients With First Pulmonary (Lung) Recurrence of Osteosarcoma |
| Official title | A Phase II Study of Aerosolized GM-CSF (NSC# 613795, IND# 11042) in Patients With First Pulmonary Recurrence of Osteosarcoma |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Metastatic Cancer, Sarcoma |
| Intervention type | Biological, Procedure |
| Interventions | sargramostim, conventional surgery |
| Enrollment | 49 |
| Start date | Jul 1, 2004 |
| Primary completion | Jul 1, 2010 |
| Completion | Dec 1, 2013 |
| First posted | Aug 7, 2003 |
| Last update posted | Mar 30, 2015 |
| Countries | Australia, Canada, Puerto Rico, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: